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Abstract 
Gene expression of eukaryotes is regulated by various processes including mRNA degradation. 
Dysregulation of mRNA degradation is now considered to be a possible cause of various 
disease including cancer, neurodegenerative disease, diabetes, and obesity. 5’ - 3’ 
exoribonuclease Xrn1 functions at the last step of mRNA degradation. Recent studies showed 
that Xrn1 forms specific cytoplasmic messenger ribonucleoprotein (mRNP) granules in post-
synapse to regulate local translation. However, there are no physiological studies that have 
investigated the function of Xrn1 in the brain. Therefore, I generated forebrain specific Xrn1 
knockout mice for the first time and analyzed their phenotype. Interestingly, the knockout mice 
showed obesity and hyperphagia. Energy homeostasis is regulated by various organs including 
central nervous systems and peripheral metabolic tissues such as liver, pancreas, and adipose 
tissues, thus the development of obesity is often caused by the dysregulation of inter-organ 
communication. In response to metabolic cues, peripheral tissues produce hormones such as 
insulin and leptin. The hypothalamus sense changes in circulating blood glucose, insulin, and 
leptin and integrate those cues to maintain metabolic homeostasis. Blood analysis showed that 
the conditional Xrn1 knockout mice were hyperglycemic, hyperleptinemic, and 
hyperinsulinemic. Consistent with the above phenotype, I observed dysregulated expression of 
appetite and energy homeostasis related genes in the hypothalamus of the knockout mice.  
These data suggest that Xrn1 is required for the regulation of appetite and energy homeostasis 
related gene expression in the hypothalamus, and thus Xrn1 plays a role in energy expenditure 
and control of obesity. 
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Chapter 1 Introduction   
Eukaryotic gene expression begins with transcription. Transcribed messenger RNA (mRNA) is 
processed in the nucleus to become mature mRNA. Mature mRNA is transported from the 
nucleus to the cytoplasm where it is used as a template for translation. After translation, all 
mRNAs are eventually degraded. Initially, many studies focused on transcription. However, it 
is now clear that transcription is just one step in the process of gene expression. In the past few 
decades, many enzymes involved in mRNA processing, transport, and mRNA decay have been 
identified. It is apparent like transcription itself, that these steps are also highly regulated (Chen 
and Shyu 2011, Garneau, Wilusz, and Wilusz 2007). Importantly, changes in mRNA decay 
rates alter transcript levels and thus affect protein abundance. Moreover, alterations of mRNA 
stability are reported in several diseases such as cancer, neurodegenerative disease, diabetes, 
and obesity (Audic and Hartley 2004, Linder, Fischer, and Gehring 2015, Mang et al. 2015). 
Therefore, the regulation of mRNA decay is receiving attention. Remarkably, it has also 
become clear that the regulation of mRNA degradation is linked to both transcription and 
translation (Braun and Young 2014, Collart and Reese 2014, Radhakrishnan and Green 2016).  
It is noteworthy that a 5’-3’ exoribonuclease, Xrn1, has been proposed to play a key 
role in mRNA decay-transcription feedback regulation in yeast (Haimovich et al. 2013, Sun et 
al. 2013, Braun et al. 2014) and also functions in local translation suppression in post synaptic 
neuron (Luchelli, Thomas, and Boccaccio 2015). In this literature review section, I will briefly 
explain the main pathway of mRNA decay and the mRNA decay factors involved in each step. 
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I will also discuss decay-transcription feedback regulation and the coupling mechanism of 
translation and mRNA degradation. Furthermore, I will review the functions and importance of 
mRNA decay factors in various physiological phenomena by introducing the studies of loss of 
function mutations in mRNA decay pathway in model organisms. 
  
1.1 Introduction to mRNA degradation in eukaryotes 
Eukaryotic mRNAs have two unique structures, a 7-methyl guanosine cap (m7G-cap) structure 
at the 5’ end and a poly(A) tail at the 3’ end. These structures provide effective protection 
against exoribonucleases; hence, these structures are related to mRNA stability (Chen and Shyu 
2011, Garneau, Wilusz, and Wilusz 2007). In the normal mRNA degradation pathway, the first 
step is a shortening of the poly(A) tail, a process called deadenylation. Deadenylation is 
generally regulated by two distinct deadenylases, Pan2-Pan3 and the Ccr4-Not complex. Pan2-
Pan3 is thought to function in the first stage of deadenylation (Yamashita et al. 2005). Pan2 has 
catalytic activity and belongs to the RNaseD superfamily. However, Pan3 does not have a 
catalytic domain, so it is thought to be the regulatory subunit (Moser et al. 1997, Parker and 
Song 2004). When mature mRNAs are transported from the nucleus to the cytoplasm, they have 
poly(A) tails of approximately 200 – 250 nt. Because this is rather long, in mammalian cells 
these tails are associated with many poly(A) binding proteins (PABPs). PABPs facilitate the 
interaction between the poly(A) tail and Pan2-Pan3, and they activate its deadenylase activity. 
In Pan2-Pan3 mediated deadenylation, poly(A) tails are shortened slowly and synchronously. 
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This reaction is mediated by the distributive enzyme activity of Pan2-Pan3; thus, after it 
hydrolyzes just a few nucleotides, it switches the target to another poly(A) tail. Pan2-Pan3 trims 
poly(A) tails to about 110nt, and subsequently, Pan2-Pan3 dissociates from poly(A) tails 
because the shortened poly(A) tails bind fewer PABPs. After the dissociation of Pan2-Pan3, 
the Ccr4-Not complex is recruited to the 3’ poly(A) tail and functions in the second stage of 
deadenylation (Chen and Shyu 2011, Garneau, Wilusz, and Wilusz 2007). The Ccr4-Not 
complex is a large, multi-subunit protein complex consists of at least 10 core subunits, Cnot1-
Cnot3, Cnot6, Cnot6l, and Cnot7-Cnot11 in humans (Shirai et al. 2014). The complex 
hydrolyzes targeted poly(A) tails nearly completely before switching the target. Therefore, the 
reaction is asynchronous within each mRNA species. Thus, the second step of deadenylation is 
often considered the rate-limiting step of mRNA degradation (Chen and Shyu 2011).  
Although deadenylated mRNAs are occasionally become re-adenylated and re-enter 
translation, all mRNAs eventually undergo the next irreversible stage of mRNA decay. After 
deadenylation, there are two types of irreversible stages. One is decapping, followed by 5’ to 3’ 
decay. Decapping is regulated by the Dcp1-Dcp2 complex. Dcp2 possesses a MutT domain, 
which is commonly found in pyrophosphatases, thus it cleaves the m7G-cap, releasing m7GDP 
and a 5’ monophosphorylated mRNA body. Initially, Dcp1 was also reported to have decapping 
activity (LaGrandeur and Parker 1998), however, further studies have shown that it rather 
functions as an activator of Dcp2 by promoting the formation and stabilization of its active 
form. (Steiger et al. 2003, She et al. 2008). Finally, deadenylated and decapped mRNAs are 
degraded by the major cytoplasmic exoribonuclease Xrn1 in a 5’ to 3’ direction. It is noteworthy 
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that an additional scaffold protein Edc4 facilitates the interaction between Dcp1 and Dcp2 in 
metazoans. Moreover, Edc4 also binds to Xrn1, suggesting the coupling of decapping and 5’ to 
3’ mRNA decay (Chang et al. 2014, Braun et al. 2012).  
Another irreversible step is 3’ to 5’ mRNA decay, regulated by exosomes. Exosomes 
are large protein complexes consisting of 10-12 subunits that form a ring structure. The core 
subunit of an exosome is Dis3, that belongs to the RNaseII family (Garneau, Wilusz, and 
Wilusz 2007, Dziembowski et al. 2007). Six subunits (RRP41, RRP42, RRP43, RRP45, RRP46, 
Mtr3) have RNase PH domains although whether they have a catalytic activity or not is still 
unclear. The remaining three subunits (RRP4, RRP40, and CSL4) form RNA-binding subunits 
and share homology with RNA binding proteins, which are classified as either S1 or KH RNA-
binding proteins (Allmang et al. 1999). Exosome can also degrade mRNAs having an m7G-cap 
structure. In this case, the remaining m7G-cap structure is removed from the oligomer by 
scavenger decapping enzyme Dcps (Liu et al. 2002).  
I have reviewed the studies about the two major mRNA degradation pathways and 
mRNA decay factors (Figure 1.1). More recently, lots of studies have shown that these factors 
do not only function in mRNA degradation, but also affect mRNA transcription. In the next 
section, I will introduce recent studies about mRNA decay-transcription feedback regulation 
with an emphasis on Xrn1, the key regulator of this phenomenon.  
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Figure 1.1| The two major mRNA decay pathways in eukaryotes.
Schematic illustration of the two major mRNA decaypathways, a complete description 
is provided in the main text. Figure adapted from Garneau, Wilusz, and Wilusz (2007)  
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1.2 Feedback regulation between mRNA degradation and transcription via Xrn1 
Transcription occurs in the nucleus and mRNA degradation occurs in the cytoplasm. Since 
these two events happen in separated cellular compartments, it is understandable that 
researchers initially did not consider the possibility of coupling mechanisms between 
transcription and degradation. However, many experimental results have suggested the 
existence of feedback regulation between transcription and degradation (Collart and Reese 
2014). For example, global transcriptome analysis showed that changes in the eventual 
transcript levels are generally small in mutants having defective mRNA synthesis or mRNA 
decay (Sun et al. 2012). This indicates that the existence of compensatory mechanisms, since 
the balance between synthesis and decay determines steady-state mRNA levels. This 
mechanism is called buffering and is thought to maintain a steady-state level of mRNAs (Collart 
and Reese 2014).  
The first evidence came from the study of yeast Rpb4 and Rpb7, which are 
dissociable subunits of RNA polymerase II (Pol II) that forms heterodimeric Rpb4/7. The 
Rpb4/7 heterodimer can bind to mRNAs by interacting with Pol II in the nucleus and they are 
exported from the nucleus to the cytoplasm together with mRNAs (Choder 2004). A mutation 
in the core subunit of Pol II that abolishes the interaction of Rpb4/7 with Pol II and mRNAs, 
impairs transcription and also affects deadenylation of several mRNAs (Lotan et al. 2005).  
Additional evidence of coupling between decay and transcription came from the 
function of the Ccr4-Not complex in transcription initiation and elongation (Collart and Reese 
2014, Collart 2016). Not5, a yeast homologue of mammalian Cnot3, interacts with tata-binding 
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protein (TBP) and TBP-associating factors (TAF). TBP and TAFs are the components of the 
general transcription factor, transcription factor II D (TFIID), and the integrity of the TFIID is 
required for the interaction between Not5 and TBP and TAFs, suggesting that Not5 interacts 
with TBP and TAFs incorporated into TFIID (Badarinarayana, Chiang, and Denis 2000). Also, 
Not2 interacts with Ada2, a component of SAGA (Spt-Ada-Gcn5 acetyltransferase) complex 
(Benson et al. 1998, Russell, Benson, and Denis 2002). SAGA complex possesses both histone 
acetyltransferase and histone deubiquitinase activity, and functions in both transcription 
activation and transcript elongation (Koutelou, Hirsch, and Dent 2010). In addition, analysis of 
the Not1 mutant strain in yeast showed that the Ccr4-Not complex is required for precise control 
of the recruitment of TFIID and SAGA to promoter regions (James, Landrieux, and Collart 
2007). Also, it has been reported that Cnot2 and Cnot9 can repress reporter gene activity in 
human cell lines (Jayne et al. 2006, Zwartjes et al. 2004).  
Transcription elongation sometimes causes backtracking of RNA Pol II; therefore, 
protein complexes called elongation factors (EFs) are required for transcription elongation 
(Cheung and Cramer 2011). The Ccr4-Not complex is also considered one of the EFs (Collart 
2016). Recently, it has been reported that the Ccr4-Not complex binds to the transcription 
elongation complex via interaction with Rpb4/7 heterodimers in yeast (Babbarwal, Fu, and 
Reese 2014). Also, the CCR4-NOT complex directly interacts with TFIIS, which is another key 
molecule of transcription elongation (Dutta et al. 2015, Kruk et al. 2011). From the above, the 
initial studies about decay-transcription relations focused mainly on Rpb4/7 and the Ccr4-Not 
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complex. However, three independent groups have newly identified key molecules in the 
buffering mechanism in yeast (Braun and Young 2014).  
Sun et al have developed a new technique called comparative dynamic transcriptome 
analysis (cDTA) (Sun et al. 2012). cDTA allows for quantitative monitoring of mRNA 
synthesis rate and decay rate in Saccharomyces cerevisiae cells by using Schizosaccharomyces 
pombe cells as a spike-in control. By using this method, Sun et al observed that point mutation 
in the largest Pol II subunit Rpb1 that impairs transcription leads to a decrease in synthesis rate 
as predicted, but also a decrease in decay rate. Similarly, they observed that yeast strain lacking 
deadenylase subunits of the Ccr4–Not complex shows a decrease in decay rate as predicted, but 
also a decrease in synthesis rate. Based on the cDTA data, they made the extended kinetic model 
of mRNA turnover. Briefly, they assumed that there is a global transcription modulator and a 
global degradation modulator that affect the synthesis rate and decay rate, respectively. By 
analyzing the model, they proposed that decay-transcription feedback is achieved by a factor 
that functions as a degradation enhancer and a transcription repressor. Previous work showed 
that both Rpb4/7 and the components of Ccr4–Not complex function as a transcription activator 
except for Cnot2 and Cnot9, thus they conclude that other factors are required for the buffering 
system (Sun et al. 2012).  
Based on this assumption, Sun et al examined 46 yeast mutant strains lacking mRNA 
decay factors by cDTA method. 45 out of 46 mutant strains showed buffered total mRNA level. 
Only the strain lacking the 5’ to 3’ exonuclease Xrn1 (∆xrn1) could not buffer the transcript 
Chapter 1 | Introduction 


level. The strain showed 3.2-fold increase in total mRNA levels, because of 2-fold decrease in 
decay rate and 1.6-fold increase in synthesis rate (Sun et al. 2013).  
To clarify whether the increase in synthesis rate observed in ∆xrn1 strain is due to 
the function of Xrn1 in the nucleus, they used anchor-away technique that allows for pulling 
out target proteins from the nucleus (Haruki, Nishikawa, and Laemmli 2008). As they expected, 
Xrn1 anchor-away strain showed increased synthesis rate. Thus, Sun et al assumed that nuclear 
localized Xrn1 acts as a transcription repressor. However, they could not observe direct 
interaction between Xrn1 and chromatin by ChIP methods nor direct transcriptional activity of 
Xrn1 by transcription assay (Sun et al. 2013).  
Therefore, they investigated other transcription repressors that may function in a 
Xrn1-dependent manner and found transcription repressor Nrg1 as one of the buffering 
machinery (Sun et al. 2013, Vyas et al. 2005). From cDTA results, they found that the synthesis 
rate of Nrg1 was anti-correlated with the median decay rate of the yeast mutant strains, 
indicating that Nrg1 is the transcription factor that is induced when decay rate is globally 
decreased. To clarify the functional relationship between Nrg1 and Xrn1, they overexpressed 
Nrg1 in both wild type yeast strain and ∆xrn1 strain. The result showed that wild type yeast 
strain overexpressing Nrg1 showed slow-growth phenotype because of its transcription 
repressor activity. On the other hand, overexpression of Nrg1 in ∆xrn1 strain did not affect cell 
growth. Thus, the authors concluded that Xrn1 is required for Nrg1 to function as a transcription 
repressor. This idea can help understanding of cDTA data set of 46 yeast strains. Yeast strains 
lacking mRNA decay factors have lower median decay rate, thus Nrg1 synthesis rate is 
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increased in those strains. Induced Nrg1 functions as a global transcription repressor that 
eventually leads to reduction of median synthesis rate and thus transcript level would be 
buffered. However, only ∆xrn1 mutant strain cannot buffer total transcript level because 
induced Nrg1 cannot work as a transcriptional repressor since ∆xrn1 strain lacks Xrn1 protein. 
Therefore, Sun et al conclude that Xrn1 functions as a sensor of cellular mRNA decay status 
and Nrg1 is the effector of the buffering system that tunes the global synthesis rate (Figure 1.2) 
(Sun et al. 2013). 
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Figure 1.2| Proposed diagram of Xrn1-dependent feedback regulation 
via indirect activation of transcription repressor.  
Complete description is provided in the main text. Figure Adapted from Sun et 
al. (2013). 
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At the same time, Haimovich et al also published paper that conclude Xrn1 is the key 
molecule of decay-transcription feedback mechanism (Haimovich et al. 2013). In this paper, 
the authors used different method to monitor mRNA decay, synthesis and mRNA abundance 
compared with Sun et al. For example, mRNA decay was measured by thiolutin shutoff assay 
that uses transcription inhibitor thiolutin, mRNA synthesis was measured by Genomic run on 
(GRO) assay, and RNA abundance was measured by microarray analysis. Due to the difference 
of measurement methods, there was a discrepancy in the data of synthesis rate and RNA 
abundance of ∆xrn1 mutant strain. In Haimovich’s paper, ∆xrn1 mutant strain showed 4.6-fold 
decrease in synthesis rate and slight decrease in mRNA abundance. Sun et al mentioned about 
this inconsistency and said that Haimovich’s methods were not as accurate as cDTA, because 
cDTA allows for normalization between different yeast strains and evaluation of absolute 
changes (Sun et al. 2013).  
Based on the decrease of synthesis rate in ∆xrn1 mutant, Haimovich et al assumed 
that Xrn1 functions as a transcription activator and conducted following research. First, they 
made mutant strain having point mutation in Xrn1 catalytic domain that abolishes exonuclease 
activity of Xrn1 (Xrn1D208Ap) and performed transcription induction assay with various 
stimulus. The results showed that xrn1D208A strain showed severe defects in transcription 
induction compared with both wild type and ∆xrn1 strain. Also, they performed Fluorescent in 
situ hybridization (FISH) analysis to detect specific nuclear transcription sites (TSs) of TEF4 
mRNAs in wild type, ∆xrn1 and xrn1D208A strain. They found that in xrn1D208A strain, the 
fraction of cells having TSs was significantly less compared with wild type. Also, they found 
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that both ∆xrn1 and xrn1D208A strain showed less intensity of TSs signal compared with wild 
type, indicating that wild type TSs contained two or more transcript elongating. These results 
also support the idea that Xrn1 protein functions in transcription initiation and elongation or 
both (Haimovich et al. 2013).  
Next, to investigate functions of Xrn1 in nucleus, they used temperature-sensitive 
nuclear export mutant (exp1-1/mex65-5) and examined nucleocytoplasmic shuttling of mRNA 
decay factors. Localization analysis using GFP tagged proteins revealed that nuclear 
localization of enzyme dead Xrn1D208Ap was strongly impaired. The authors also generated 
different mutated Xrn1 proteins, such as Xrn1R101Gp and Xrn1H41Dp. Both point mutations 
disrupt the interaction between Xrn1 and decapped RNA, but not enzymatic activity. In addition, 
they generated Xrn1D208A/R101Gp double mutated protein. Xrn1R101Gp and Xrn1H41Dp showed 
impaired nuclear localization but not as worse as Xrn1D208Ap. Interestingly, Xrn1D208A/R101Gp 
could partially rescue the nuclear localization ability compared with Xrn1D208Ap, suggesting 
Xrn1D208Ap sticking to decapped mRNA without degrading it. It is noteworthy that nuclear 
import of RFP tagged Dcp2 was also strongly impaired in xrn1D208A cells, indicating that Xrn1 
enzymatic activity is also required for the shuttling of some other mRNA decay factors 
(Haimovich et al. 2013).  
Since all tested mRNA decay factors can shuttle from the nuclear to the cytoplasm, 
Haimovich et al performed ChIP assay to examine whether mRNA decay factors (Xrn1-TAP, 
Dcp2-TAP, and Lsm1-TAP) can directly bind to chromatin or not. Unlike Sun’s paper, 
Haimovich could detect direct interaction between these decay factors and chromatin. 
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Intriguingly, these decay factors associated preferentially with transcription start-sites of genes 
coding unstable mRNAs or having high transcription rate. They also performed in vitro 
tethering assay using decay factors fused with Gal4 DNA binding domain (Gal4-BD). The 
result showed that Ccr4, Dcp2, Dhh1 and Pat1 could activate transcription, indicating that these 
decay factors might have activator domain. Interestingly, enzyme dead form Dcp2-4p also 
activated transcription. Thus, at least Dcp2, does not require enzymatic activity to function as 
a transcriptional activator. Moreover, they also reported that Gal4-BD-Dcp2 could not activate 
transcription in the case of both ∆xrn1 and xrn1D208A cells, suggesting that Xrn1 is required for 
transcriptional activity of some decay factors, like as the case of Nrg1 in Sun’s paper 
(Haimovich et al. 2013).  
Haimovich also examined whether Xrn1 deletion has some effects on transcription 
elongation. They performed RNA Pol II ChIP-on-chip (RPCC) using a membrane containing 
5’ and 3’ probes to detect relative Pol II distribution in 5’ area and 3’ area. Also, they performed 
Genomic run-on (GRO) to detect active Pol II fraction in 5’ area and 3’ area. Their data revealed 
that in Xrn1 mutant strain (∆xrn1 and xrn1D208A), Pol II was accumulated in 3’ region of the 
genes. However, GRO did not show biased signal in those mutants, indicating that accumulated 
Pol II in mutant strains were not elongating. To confirm this observation, they also examined 
phosphorylation status of Pol II (Ser2P-CTD), which is often used as an indicator of elongating 
Pol II. The results clearly showed that phosphorylation of Ser2-CTD was reduced in Xrn1 
mutants, suggesting that deletion or disruption of Xrn1 has some impact to Pol II elongation 
activity (Haimovich et al. 2013). They found that including Xrn1, deletion of decay factors 
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causes downregulation of transcription. All examined decay factors have nucleocytoplasmic 
shuttling ability and shuttling ability of some decay factors is impaired when the function of 
Xrn1 is disrupted. Also, several decay factors bind to transcription start sites of genes coding 
unstable mRNAs or having high transcription rate and Xrn1 is required for the transcriptional 
activity of some decay factors. Therefore, they conclude that Xrn1 is the key molecule of 
mRNA decay-transcription feedback loop and some mRNA decay factors function as 
transcription activator by shuttling from the cytoplasm to nucleus after they degrade mRNAs 
(Figure 1.3) (Haimovich et al. 2013). 
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Figure 1.3| Proposed diagram of Xrn1-dependent feedback regulation 
and nucleocytoplasmic shuttling of mRNA decay factors.  
Complete description is provided in the main text. Figure adapted from Haimovich, G 
et al. (2013). 
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The key difference of Sun and Haimovich’s paper was the results of synthesis rate in 
∆xrn1 strain. For example, Sun’s data showed ∆xrn1 strain had 1.6-fold increased synthesis 
rate. Hence, they assumed that Xrn1 functions as transcription repressor, and conduct following 
research. On the other hands, Haimovich’s data showed ∆xrn1 strain had 4.6-fold decreased 
synthesis rate. Thus, they assumed that Xrn1 functions as transcription activator. This 
difference might be due to the difference of methods they took. In addition, their ChIP assay 
results was also inconsistent. Sun could not detect the direct interaction between Xrn1 and 
chromatin, but Haimovich could. From the above, it is likely that Xrn1 is a key molecule of the 
feedback regulation. However, whether Xrn1 functions as a transcription activator or repressor, 
and whether Xrn1 directly binds to chromatin and affect transcription or indirectly control 
transcription via other molecules such as Nrg1 are remains to be elucidated. 
Both Sun and Haimovich’s group used yeast grown in the high glucose condition. 
Another group has studied mRNA decay-transcription feedback regulation in a glucose 
depleted condition. Under stress conditions such as glucose depletion, cells regulate gene 
expression through both transcriptional and post-transcriptional regulation and adopt to new 
environments. Snf1, the Saccharomyces cerevisiae ortholog of adenosine monophosphate–
activated protein kinase (AMPK), signaling pathway is activated by glucose depletion and 
enabling adaptive cellular responses. Braun et al. performed phosphoproteomics analysis and 
identified Xrn1 as a Snf1-dependent phosphorylated protein (Braun et al. 2014). Moreover, they 
found that Xrn1 is required for transcription and glucose-induced mRNA decay of Snf1-
dependent genes (Braun et al. 2014).  
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Figure 1.4| Xrn1 mediated mRNA decay-transcription feedback 
models proposed by three different groups. 
Schematic illustration of the circular regulation of transcription and mRNA 
degradation. Complete description is provided in the main text. Figure adapted from 
Braun and Young (2014) 
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Compared with outcomes in yeast, research about mRNA decay-transcription 
feedback mechanisms in mammals has not progressed very far. Recently, Abernathy et al. 
reported that Xrn1-dependent feedback regulation is conserved in mammals (Abernathy et al. 
2015). In addition, they also found that changes in mRNA degradation are somehow sensed in 
order to activate transcriptional changes. The authors examined the effects of a cytoplasmic 
mRNA-targeting viral endonuclease, SOX. Gamma-herpesviruses encode this protein and it 
cleaves most cellular mRNAs. Thus, either infection with the virus or expression of the viral 
protein in mammalian cell lines accelerates mRNA decay. Importantly, mRNA decay caused 
by viral nucleases requires host Xrn1 protein to eliminate cleaved mRNAs. Therefore, the 
authors considered the possible relationship between viral infection and Xrn1-mediated 
feedback regulation.  
Briefly, their results showed that accelerated mRNA decay triggered by viral 
nucleases leads to repression of transcription of host genes, but viral genes can escape this 
transcriptional repression, so the Xrn1-dependent feedback mechanism is beneficial to viruses, 
suggesting that Xrn1-dependent feedback is also important for physiological mechanisms in 
mammals. 
  
1.3 mRNP granules and local translation regulation 
After transcription, mRNAs are exported to cytoplasm and used as a template of translation 
then degraded. These processes are organized and controlled by various mRNA binding 
proteins and non-coding RNAs. Under certain condition, these factors and mRNAs form 
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membrane less cytoplasmic foci known as messenger ribonucleoprotein particles (mRNPs) 
(Parker and Song 2004). mRNAs incorporated into mRNPs are either be degraded or 
translationally suppressed. mRNPs are classified based on the difference in the composition 
and the formation process (Buchan and Parker 2009). Most well studied mRNPs are processing 
bodies (P-bodies) and stress granules. P-bodies contain mRNA decay machineries such as the 
CCR4-NOT complex, decapping complex, and Xrn1. However, it does not contain ribosomal 
subunits and poly A binding proteins (PABPs) suggesting that P-bodies mainly functions as the 
place for deadenylation dependent mRNA decay. On the other hands, stress granules contain 
translation initiation factors (eIF4E, eIF4G, eIF4A, eIF3, and eIF2), PABPs, and 40S ribosomal 
subunits. mRNAs associated with stress granules are translationally silenced, but they can re-
enter into translation when translation arrest is relieved (Parker and Song 2004, Buchan and 
Parker 2009).  
 It is noteworthy that Xrn1 was the first mRNA degradation factor detected in 
cytoplasmic foci in mouse cells (Bashkirov et al. 1997). Xrn1 is detected both in P-bodies and 
stress granules (Buchan and Parker 2009, Thomas et al. 2009). mRNPs are not only controlling 
the mRNA decay and translation, but also play important roles in mRNA transport. mRNA 
transport and local translation modulate neuronal development. Neuronal granules contain 
mRNA transport related protein Staufen that is thought to mediate translational repression 
and/or mRNA transport in neuronal cells (Kiebler and Bassell 2006). In Drosophila, Pacman, 
which is the ortholog of Xrn1, is found in neuronal transport granules (Barbee et al. 2006). Also, 
Luchelli et al. have shown that Xrn1 forms unique cytoplasmic foci at the post synapse of rat’s 
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hippocampal neuron (Luchelli, Thomas, and Boccaccio 2015). They named it synaptic XRN1 
bodies (SX-bodies) and found that SX-bodies are different from other RNA granules such as 
P-bodies, stress granules, and other known neuronal granules in terms of the composition and 
the forming process. At the post synapse, the RNA regulator Smaug1 and Fragil X Mental 
Retardation Protein (FMRP) containing cytoplasmic foci are observed and they are called S-
foci and FMRP granules, respectively. S-foci and FMRP granules regulate the mRNA stability 
and local translation at the post-synapse. Previous studies have shown that NMDAR stimulation 
triggers the dissolution of S-foci but does not affect the number and size of FMRP granules. On 
the other hand, the activation of metabotropic glutamate receptors mGluR triggers the rapid 
dissolution of the S-foci and FMRP granules (Thomas and Boccaccio 2016). The SX-bodies do 
not contain Dcp1a, Smaug, and FMRP, suggesting that they are different from canonical p-
bodies, S-foci, and FMRP granules. Moreover, in contrast to other neuronal granules, SX-
bodies increase in size and number upon NMDAR stimulation, which triggers a global 
translational silencing (Luchelli, Thomas, and Boccaccio 2015). These results clearly showed 
that SX-bodies are unique and Xrn1 should have key roles in local translation of mRNAs under 
the specific stimuli at post synapse, although the target transcripts of the local translation 
suppression are still unknown (Figure 1.5) (Thomas and Boccaccio 2016). 
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Figure 1.5| Comparison of different mRNA silencing foci at post 
synapse under various stimuli. 
Schematic illustration of the dynamics of RNA granules upon different stimuli. 
Complete description is provided in the main text. Figure adapted from Thomas and 
Boccaccio (2016) 
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1.4 Role of mRNA degradation in physiology 
mRNA degradation factors have multifunctional roles in gene expression process. Thus, they 
are also responsible for various physiological phenomenon. In this section, I will focus on 
findings in knockout models of mRNA degradation factors mainly in mammalian systems and 
will occasionally refer to findings from non-mammalian systems.  
The Ccr4-Not complex is one of the most well-studied mRNA degradation factors in 
mammalian systems. The subunits of the CCR4–NOT complex are ubiquitously expressed in 
adult mice with some tissue preferences, such as brain, testis, and metabolic tissues (Chen et al. 
2011). Depletion of Cnot1, Cnot2, and Cnot3 causes cell death such as apoptosis and 
necroptosis in mammalian cells. (Ito, Takahashi, et al. 2011, Ito, Inoue, et al. 2011, Suzuki et 
al. 2015). Also, homozygous knockout of some subunits of the CCR4-NOT complex leads to 
embryonic lethality (Shirai et al. 2014, Morita et al. 2011). Muscle specific depletion of Cnot1 
and Cnot3 causes heart failure via upregulation of the key autophagy regulator Atg7 
(Yamaguchi et al. 2018). Cnot3 is also required for B cell development (Inoue et al. 2015), 
bone mass metabolism (Watanabe et al. 2014), and postnatal liver function maturation (Suzuki 
et al. 2019). In addition, Cnot7, a catalytic subunit of the CCR4-NOT complex, is essential for 
male fertility (Berthet et al. 2004, Nakamura et al. 2004). Importantly, the CCR4-NOT complex 
is regulating energy homeostasis in liver and adipose tissues via controlling the stability of 
specific mRNAs (Morita et al. 2011, Takahashi et al. 2015, Morita et al. 2019, Takahashi et al. 
2019, Salem et al. 2019). 
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Compared to the deadenylation complex, physiological studies in decapping enzymes 
and exonucleases are limited. Mutations in DCAP-1 and DCAP-2 , which are the homologue 
of DCP1-DCP2 decapping complex in C. elegans, reduce longevity and stressresistance in C. 
elegans(Rousakis et al. 2014) and this phenotype is rescued by expressing DCAP-1 specifically 
in neuronal cells (Borbolis et al. 2017). This result suggests that decapping complex plays 
important roles in neurons to regulate specific genes related to stress resistance and life span in 
worm. On the other hand, DCP2 hypomorphic knockout mice are fertile, viable, and grow 
normally compared to their littermates (Song, Li, and Kiledjian 2010). In yeast, disruption of 
5’ to 3’ exoribonuclease Xrn1 causes severe growth defect (Larimer and Stevens 1990). siRNA-
mediated knockdown of Xrn1 in C. elegans causes embryonic lethality due to the failure of 
ventral epithelial enclosure during embryogenesis (Newbury and Woollard 2004). Interestingly, 
hypomorphic mutations in Pacman, which is the homologue of XRN1 in D. melanogaster, also 
causes defect in dorsal/thorax closure and epithelial sheet sealing that is relevant to ventral 
epithelial enclosure in C. elegans (Grima et al. 2008, Jones, Zabolotskaya, and Newbury 2012). 
Mutations in Pacman also causes defects in spermatogenesis and oogenesis, thus XRN1 is 
required for male and female fertility in D. melanogaster (Zabolotskaya et al. 2008, Lin et al. 
2008). In mouse testis, XRN1 is recruited to the transcripts having m6A modification by 
YTHDC2, a YTH domain containing m6A reader protein, and thus involving in 
spermatogenesis (Wojtas et al. 2017). As these studies showed, mRNA degradation is important 
for various physiological phenomena. However, further analysis is necessary to understand the 
roles of its individual factors in tissue function and homeostasis.  
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1.4 Aim of the study 
I have briefly introduced the main pathway and function of mRNA degradation systems. Also, 
I have reviewed mRNA decay-transcription feedback regulation and local translation control 
via mRNPs. In each section, I have shown that Xrn1 has important roles, however, there has 
been no knockout mouse studies of XRN1. Therefore, the main aim of my project is to elucidate 
the functional role of Xrn1 in mouse physiology by generating and analyzing Xrn1 knockout 
mice. In addition, several studies have already shown that Xrn1 must play important roles in 
neurons and brain, thus I will establish brain specific Xrn1 conditional knockout mice and 
analyze its phenotypes to elucidate the physiological role of Xrn1 in mouse brain. 
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Chapter 2 Materials and Methods  
2.1 Mice 
Xrn1flox/+ mice were generated by ssODN (single-strand oligodeoxynucleotides)-mediated 
knock-in with CRISPR-Cas in C57BL/6N zygotes in which loxP sites flank exons 2 and 6 of 
the Xrn1 gene (accession no. CDB0007E, RIKEN). Two gRNAs and ssODN targeting intron 1 
and intron 6 of the Xrn1 gene, and Cas9 were injected into wild type zygotes. The gRNA and 
ssODN sequences were listed in Table 2.1. Confirmation of loxP insertion in cis orientation 
was performed by genotyping in F1 offspring. Primers used for detection of wild type and 
floxed alleles are listed in Table 2.2.  
CAG-Cre mice that express Cre recombinase gene under the control of the 
cytomegalovirus immediate early enhancer-chicken b-actin hybrid (CAG) promoter were used 
to generate whole-body knockout mice of Xrn1. To generate whole-body knockout mice of 
Xrn1, we crossed Xrn1flox/flox mice with CAG-Cre+/-mice. Primers used for detection of wild 
type, floxed, and knockout alleles are listed in Table 2.2.  
Camk2a-Cre mice that express Cre recombinase gene under the control of the mouse 
calcium/calmodulin-dependent protein kinase II alpha (Camk2a) gene promoter were used to 
generate forebrain specific knockout mice of Xrn1. To generate forebrain specific knockout 
mice of Xrn1, we crossed Xrn1flox/flox mice with Xrn1flox/+, Camk2a-Cre+/-mice. Primers used 
for genotyping of wild type and floxed alleles are listed in Table 2.2. All mice used were 
maintained under a 12-hr light/12-hr dark cycle in a temperature- controlled (22°C) barrier 
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facility with free access to water and normal chow diet (NCD, CA1- 1, CLEA Japan). The 
gender and age of mice used for experiments were indicated in the figure legends. Mouse 
experiments were approved by the animal experiment committee at the Okinawa Institute of 
Science and Technology Graduate University (OIST).  
 
2.2 Genotyping 
Tails from 3 weeks old mice were lysed in 50 µl of DNA extraction solution 1 (25 mM NaOH, 
0.2 mM EDTA) for 20 minutes at 95℃. Followed by addition of 50 µl of DNA extraction 
solution 2 (40 mM Tris-HCl pH 5.0). Samples were vortexed and spin downed by tabletop 
centrifuge. 0.5 µl of the lysate was used as a template for PCR amplification. All genotyping 
primers are listed in Table 2.2. 

PCR mixture: 
10x NH4 reaction buffer  2 µl
2.5 mM dNTP   2 µl
50 mM MgCl2   1.2 µl
BIOTAQ DNA Polymerase  0.1 µl
10 µM of primer (reverse + forward)  0.5 µl
template DNA   0.5 µl 
ddw    13.7 µl  
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PCR amplification cycle of genomic DNA (Step 2 to Step 4 was repeated for 35 cycles) 
• Step1 2 minutes at 95 °C 
• Step2 30 sec at 95 °C  
• Step3 30 sec at 60 °C  
• Step4 45 sec at 72 °C 
• Step5 5 minutes at 72 °C 
PCR products were run on 2% agarose gel with 2x loading sample buffer.  

2.3 Daily food intake analysis 
Prior to measuring daily food intake, animals were single-caged and kept under a normal 12-hr 
light-dark cycle. At least after 1day of acclimation, the weight of food supplied was measured. 
24 hours after, the weight of food remaining was measured again. The value of subtraction of 
the weight of food remaining from the weight of food supplied was used as daily food intake. 
 
2.4 Blood analysis 
Random blood glucose was measured from tail vein blood using glucometer (Glutest Neo 
Sensor, Sanwa Kagaku Kenkyusho). The mice used for collecting serum were euthanized by 
isoflurane, and blood was taken from inferior vena cava. Whole blood was kept at room 
temperature until forms clot, then centrifuge at 2000g for 10 minutes to separate serum. 
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Concentrations of serum insulin and serum leptin was measured by Mouse Insulin ELISA kit 
(Mercodia) and Mouse Leptin ELISA kit (ab199082, Abcam). 
 
2.6 Metabolic analysis 
6-7-week-old mice were acclimated for 3 days in a metabolic chamber with food and water 
under a normal 12-hr light-dark cycle. Oxygen consumption (VO2), carbon dioxide production 
(VCO2), respiratory exchange ratio (RER), and energy expenditure were measured after 
acclimation with an Oxymax system (CLAMS; Columbus Instruments, Columbus, OH, USA). 
For home cage activity monitoring, mice (6-8 weeks of age) were housed individually in cages 
with a lid containing CCD camera and white and IR LED unit (O'HARA & CO.,LTD.) under 
a normal 12-hr light-dark cycle and had free access to both food and water. After 1-day 
acclimation, the subject’s distance traveled in every minute was measured with the software 
(O'HARA & CO.,LTD.). 
 
2.7 Immunoblotting 
For protein expression analysis, the mice were euthanized by isoflurane and perfused with PBS. 
The tissue was frozen in liquid nitrogen immediately after excision and kept in -80°C until used. 
The tissue was homogenized in TNE buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 2 mM 
EDTA, 1% NP40, EDTA free Protease Inhibitor Cocktail (Nakarai Tesque), 1 mM PMSF, 
1mM b-Glycerophosphate, 1mM Na2Vo3, and 1mM NaF) by passing the tissue in lysis buffer 
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10 times through a 24 G needle and incubated for 30 minutes on ice. Lysate were clarified by 
centrifugation at 16,000 g for 10 min at 4°C. Protein concentration in the lysate was measured 
using Pierce BCA protein assay Kit (Thermo Fisher Scientific) and dissolved in 1XSDS sample 
buffer (containing 3% SDS, 10 % glycerol, and 5% b-mercaptoethanol). Proteins in the lysate 
were then reduced through boiling on heat block for 5 minutes at 95°C and subjected to SDS-
polyacrylamide gel (SDS-PAGE) electrophoresis. Afterward, proteins separated on the SDS-
PAGE were electro-transferred onto 0.45µm polyvinylidene difluoride membranes (PVDF, 
Millipore cat no. IPVH00010) using wet transfer system (Nihon Eido, Tokyo, Japan). After the 
membranes were blocked with 3% skim milk/TBST (20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 
0.5% v/v Tween 20), proteins of interest were probed with appropriate specific primary 
antibodies and then horse radish peroxidase (HRP)-conjugated secondary antibodies against the 
primary antibodies’ host. Chemiluminescent signals were detected using an ImageQuant LAS 
4000 mini (GE Healthcare, Tokyo). Sequential probing of the membranes with a variety of 
antibodies was performed after inactivation of HRP with 0.1% sodium azide (NaN3), according 
to the antibody manufacturer’s protocol. Protein level was quantified using ImageJ software 
and normalized to a-tubulin.  
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2.8 Antibodies for immunoblotting
The following primary antibodies were used: XRN1 (1:5000 in Can Get Signal Solution 1 
(Toyobo); A300-443A; Bethyl Laboratories), LEPR (1:1000 in CGS Solution 1; ab177469; 
Abcam), JAK2 (1:1000 in CGS Solution 1; #3230S; Cell Signaling Technology), STAT3 
(1:1000 in CGS Solution 1; #4904S; Cell Signaling Technology), SOCS3 (1:1000 in CGS 
Solution 1; #2923S; Cell Signaling Technology), IRS1 (1:1000 in CGS Solution 1; 611394; BD 
Transduction Laboratories), PI3K (1:1000 in CGS Solution 1; #4292S; Cell Signaling 
Technology), AKT (1:1000 in CGS Solution 1; #9272S; Cell Signaling Technology), Foxo1 
(1:1000 in CGS Solution 1; #2880S; Cell Signaling Technology), PTEN (1:1000 in CGS 
Solution 1; #9559S; Cell Signaling Technology), α-Tubulin (1:1000 in 3% skim 
milk/TBST;#T9026; Sigma), and GAPDH (1: 1000 in 3% skim milk/TBST; #2118; Cell 
Signaling Technology).  
The following secondary antibodies were used: ECL anti-mouse IgG HRP-linked 
whole antibody (from sheep) (1:3000 in CGS Solution 1; NA931V; GE healthcare), ECL anti-
rabbit IgG HRP-linked whole antibody (from donkey) (1:3000 in CGS Solution 1; NA934V; 
GE healthcare) 
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2.9 Quantitative real-time RT-PCR (qRT-PCR) 
For qRT-PCR analysis, the mice were euthanized by isoflurane and perfused with PBS. The 
tissue was frozen in liquid nitrogen immediately after excision and kept in -80°C until used. 
Total RNA was isolated from the tissue by using 1 ml of ISOGEN II (Nippon gene). 1 µg of 
total RNA was used for cDNA synthesis with SuperScript Reverse Transcriptase III (Thermo 
Fisher Scientific) as follows: 
Mixture 1: 
Total RNA    1 µg 
Oligo(dT) 12-18 primers  1 µl
2.5 mM each dNTP	 	 	 4 µl 
ddw     Up to 13 µl 
Mixture 1 was boiled at 65 degrees for 5 minutes followed by at least 1 minute on ice. Then 
mixture 2 was added.
Mixture 2: 
5x First Strand buffer   4 µl
0.1 M DDT    1 µl
RNaseOut     1 µl
SuperScript III RT    1 µl 

Tubes were incubated in PCR thermal cycler with the following conditions: 50℃ for 1 hour 
and 70 ℃ for 15 minutes. cDNA was diluted 10-fold with RNase-free water. Generated cDNA 
was kept at -20 till further analysis. 
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For qRT-PCR, reactions were performed using 2.5 µl of cDNA1, 5 µl of SYBR 
Premix Ex Taq (Takara), 0.2 µl of ROX II reference dye, 0.2 µl of 10 µM primer (reverse + 
forward). qRT-PCR reactions were performed using primers listed in Table 2.1 and analyzed 
with a Viia7 sequence detection system (Applied Biosystems). Each sample was run in two 
technical replicates using the following PCR conditions: 
PCR amplification cycle of cDNA (Step 2 to Step 4 was repeated for 40 cycles) 
• Step1 95°C for 30 seconds  
• Step2 95°C for 5 seconds  
• Step3 60°C for 30 seconds  
• Step4 75°C for 15 seconds  
• Step5 60°C for 1 minute  
• Step6 95°C for 15 seconds  
Relative expression of mRNA was determined after normalization to Gapdh mRNA using the 
∆∆Ct method.  
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2.11 Immunohistochemistry 
11-week old male mice were euthanized by isoflurane and perfused with 4% PFA/PBS. After 
perfusion, the brains were dissected and further fixed in 4% PFA/PBS overnight at 4°C. The 
fixed brains were soaked in 15% sucrose/PBS for 2hours at 4°C and 30% sucrose/PBS 
overnight at 4°C. The brains were embedded in Optimal cutting temperature (OCT) compound 
and frozen at -20°C. The frozen brains were coronally sectioned at 30 μm using a Cryostat 
(Leica CM 3050S). The brain sections were kept in PBS at 4°C till used. The brains sections 
were mounted onto coated slides, then washed two times with PBS. After the slides were 
blocked with blocking buffer (PBS with 0.5 % Triton X-100 and 5% goat serum) for 1hour at 
RT, they were incubated with the either Pomc antibody (1: 250 in blocking buffer; H-029-30; 
Phoenix Pharmaceuticals) or AgRP antibody (1: 250 in blocking buffer; H-003-57; Phoenix 
Pharmaceuticals) at 4°C overnight. After several rinse in PBS-T (PBS with 0.5 % Triton X-
100), slides were incubated with secondary antibody (Goat Anti-Rabbit IgG H&L (Alexa 
Fluor® 555); ab150078; Abcam) for 2 hours at RT. Slides were then rinsed in PBS-T and 
incubated with DAPI. Fluorescent signals of secondary antibody and DAPI were detected by 
fluorescent microscopy BZ-X700 (Keyence). Obtained images are further analyzed using 
ImageJ software to quantify the signal intensity and cell numbers. 
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2.10 Proteomics analysis  
11-week old male mice were euthanized by isoflurane and perfused with PBS. The 
hypothalamus was frozen in liquid nitrogen immediately after excision and kept in -80°C until 
used. The hypothalamus was homogenized in TNE buffer (20 mM Tris-HCl (pH 7.5), 150 mM 
NaCl, 2 mM EDTA, 2 mM MgCl2, 2% SDS, 1% NP40, EDTA free Protease Inhibitor Cocktail 
(Nakarai Tesque), 1 mM PMSF, 1 mM b-Glycerophosphate, 1 mM Na2VO3, and 1 mM NaF)
by passing the tissue in lysis buffer 10 times through a 24 G needle. Following sonication, 
samples were centrifuged at 16,000 g for 10 min. Proteins in the lysate were reduced with DTT 
(final concentration of 10 mM) through boiling on heat block for 30 minutes at 60°C and 
alkylated using iodoacetamide (final concentration of 50 mM) for 30 min at room temperature 
in the dark. Protein concentration in the lysate was measured using Direct Detect assay-free 
cards with the Direct Detect spectrometer (Merck Millipore).  
For the gel‐based digestion protocols, tissue lysate containing 10 µg of protein was 
mixed with LDS buffer and resolved on NuPage 4–12% Bis-Tris protein gels (Invitrogen). The 
gel was fixed in 50% methanol and 10% acetic acid for 1hour, then stained with NOVEX 
Colloidal Blue Staining Kit (Invitrogen) for 3 h. After staining, the gel was washed with 
distilled water. The gel images were taken by ChemiDoc XRS Plus (Bio-Rad). Protein gel was 
excised into 8 pieces per lane and distained by soaked in 25 mM ammonium bicarbonate/50% 
methanol for 4 times. After dehydration by acetonitrile (ACN), the proteins in the gel pieces 
were digested overnight at 37°C with digestion buffer (5% acetonitrile, 25 mM ammonium 
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bicarbonate, 2 mM CaCl2) containing 250 ng of trypsin (Promega). Trypsin-digested peptides 
were extracted by sequential wash with 1.25% trifluoroacetic acid (TFA)/50% ACN, 0.33% 
trifluoroacetic acid (TFA)/66% ACN, and 100% ACN. The elute containing peptides was 
evaporated by EZ-2 Elite evaporator (Genevac). To purify the eluted peptides, handmade stage-
tip was used. 4 pieces of Empore disks (3M Empore High Performance Extraction Disk) were 
inserted into 200 µL micropipette tips. Before loading the sample, the stage-tip sorbents were 
activated with 50 µl of methanol (1600g, 3min, RT), cleaned with 50 µl of 0.1% TFA/60% 
ACN (1600g, 3min, RT), and equilibrated with 200 µl of 0.1% TFA (1600g, 9min, RT). The 
samples were resuspended in 50 µl of 1% TFA, then loaded to the stage-tip (1600g, 5min, RT). 
The stage-tips containing peptides were washed twice with 200 µl of 0.1% TFA (1600g, 6min, 
RT) and peptides were eluted twice with 50 µl of 0.1% TFA/60% ACN (1600g, 3min, RT). 
The elute containing peptides was evaporated by EZ-2 Elite evaporator (Genevac) and 
resuspended in 25 µl of 0.1% TFA. The peptide resuspension was analyzed by LC/MS/MS, 
using nano-Acquity LC (Waters) connected to Orbitrap Fusion Lumos (Thermo Fisher 
Scientific). Obtained mass spectrometry data was analyzed using ProteomeDiscoverer 2.2 
software (Thermo Fisher Scientific). 
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2.17 Primers 
Table 2.1| gRNA and ssODN used for Xrn1flox/+ mice generation. 
Type/name Sequence (5’-3’) 
5’gRNA CAATAATCACCGTCGAATAAAGG  
3’gRNA AAGTGTAGCTCAGCAGCCGGGGG 
5’ssODN 
AAAAACAAACCTTAATAAAACTTCAATAATCACCGTCGAAGATATCATAACTTCGTATAG 
CATACATTATACGAAGTTATTAAAGGAGGTAAAGGGAAGCCAATAGGAACGGCTAGTAAT 
3’ssODN 
CCTAGGTTAAGACCACAGAACCCAAGTGTAGCTCAGCAGCGATATCATAACTTCGTATAGC 
ATACATTATACGAAGTTATCGGGGGCTCACCTTGGGGCCCAGCCCAGTCCTGCCAAAAT 
 
Table 2.2| Primer sets used for genotyping.  
Target Primer sequence (5’-3’) Expected size 
Xrn1 
5’ Fw2: GTCTCTCCATTACTAGCCGTTCC             
5’ Re2: CTGTGTACAACTACCTGCATCTCC           
3’ Re: CATGCTTTTCTGAGACCC 
WT:204 
Flox:244 
KO:421 
CAG-Cre 
Cre Fw: TCGATGCAACGAGTGATGAG                 
Cre Re: TTCGGCTATACGTAACAGGG                  
IL-2 Fw: CTAGGCCACAGAATTGAAAGATCT         
IL-2 Re: GTAGGTGGAAATTCTAGCATCATCC 
Cre: 482 
IL-2: 324 
Camk2a-Cre 
Cre Fw: GAGGGACTACCTCCTGTACC                 
Cre Re: TGCCCAGAGTCATCCTTGGC                  
IL-2 Fw: CTAGGCCACAGAATTGAAAGATCT         
IL-2 Re: GTAGGTGGAAATTCTAGCATCATCC 
Cre: 630 
IL-2: 324 
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 Table 2.3| Primer sets used for qPCR 
Gene symbol Fworward primer (5'-3') Reverse primer (5'-3')  
mAgrp AGAAGACAACTGCAGACCGAG GTTCTGTGGATCTAGCACCTCC 
mAkt1 GTGGCAGGATGTGTATGAGAAG ACCTGGTGTCAGTCTCAGAGG 
mCart GGACATCTACTCTGCCGTGG TCGATCTGCAACATAGCGCC 
mFoxo1 GCTGGGTGTCAGGCTAAGAG AAGGGCATCTTTGGACTGC 
mGabrb1 GCAAACAAGACCAGAGTGCC AGGAGAATATTGCCGTGGGC 
mGabrg2 ATAAGGATGCTGTTCCTGCC GTGACATAGGAGACCTTGGGC 
mGapdh CTGCACCACCAACTGCTTAG GTCTTCTGGGTGGCAGTGAT 
mHras1 GAAACATCAGCCAAGACCCG TTCCGCAATTTATGCTGCCG 
mInsr TCTTTCTTCAGGAAGCTACATCTG TGTCCAAGGCATAAAAAGAATAGTT 
mIrs1 CTATGCCAGCATCAGCTTCC TTGCTGAGGTCATTTAGGTCTTC 
mIrs2 TCCAGAACGGCCTCAACTAT GGCTCCAGGAGTTCTTGTCTC 
mJak2 CGAGAAGAGTAAAAGTCCACCC GGAACACAATCATTTGCCCTTG 
mLepr GACTTGCAGATGGTCACCCA TGGGCTCAGACGTAGGATGA 
mMc3r AAAGCCCTCACCTTGATCGG AGCACCATGGCGAAGAACAT 
mMc4r CAGTACGGATACGGATGCCC GCGAGCAAGGAGCTACAGAT 
mMtor TGGCCGTTATGTCGATGGTC CAGGATCTTCCCACTCAGCC 
mNpy CCAGCCCTGAGACACTGATTT CATCACCACATGGAAGGGTCT 
mPdk1 GTTGAAACGTCCCGTGCT GCGTGATATGGGCAATCC 
mPik3r1 CTTTCCTTGTCCGGGAGAGC TGACGCAATGCTTGACTTCG 
mPomc TCTGCTACAGTCGCTCAGGG CGAGTTTGCAAGCCCGGAT 
mPten AGGCACAAGAGGCCCTAGAT CTGACTGGGAATTGTGACTCC 
mPtp1b GCTTCTCCTACCTGGCTGTC CACTGATCCTGCACTGACGA 
mPtprj CCGTGGACGTGTATGGGATT TACTGGTCCTCTGTCTGCAC 
mPvalb ACAAAGACGCTTCTGGCCG TCAGCGCCACTTAGCTTTCAG 
mSocs3 TCGGTCAGTAGGTCCGAGAG GGGAAGGCTTCTCCATCACC 
mStat3 GACTGAGGTGTACCACCAAGG AAGTTCACGTTCTTGGGGTTATTG 
mTcptp  GGTGCAGGATACTGTGGAGG ATCTGCTGCACCTTCTGAGC 
mXrn1 TTATGGCTGTTGACGGTGTG TGGCTGACCTAAAACGCCTC 
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Chapter 3 Results 
3.1 Xrn1 whole-body knockout causes embryonic lethality 
To investigate the physiological functions of Xrn1, I designed two gRNAs and ssODN targeting 
exons 2 and 6 of the Xrn1 gene (Figure 3.1.A) and Xrn1flox/+ mice were generated by ssODN-
mediated knock-in with CRISPR-Cas in zygotes. After I confirmed flox insertion in cis 
orientation, obtained Xrn1flox/+ mice were crossed with CAG-Cre mice to establish whole-body 
Xrn1 knockout mice. Xrn1+/- mice were viable, fertile and didn't show any obvious defects. 
However, whole-body Xrn1 null mice showed embryonic lethality around E10.5 and the null 
embryos showed open neural tube defects in both E9.5 and E10.5 (Figure 3.1.B). Next, I 
examined Xrn1 protein expression in embryos by immunoblotting and confirmed knockout of 
Xrn1 full length protein. Surprisingly, I observed a band below full length Xrn1 in both 
heterozygous and homozygous knockout embryos (Figure 3.2.A). The molecular weight of the 
band is around 160 kDa, and Xrn1 splicing variant lacking exon2 - exon7 has a predicted 
molecular weight of 167 kDa although this variant was not predicted (Figure 3.2.B). The 
transgenic mice were designed to delete exon 2 to 6 of Xrn1 protein, but exon 7 was skipped 
by alternative splicing to produce truncated protein in embryos. Importantly, the truncated 
protein lacks important motifs such as 5’-phosphate-binding pocket and catalytic site. Thus, I 
conclude that Xrn1 is essential and its mRNA binding activity and exoribonuclease activity is 
required for the embryonic development of mice. 
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A
B Xrn1 genotype
Stage +/+ +/- -/-
E9.5 1 10 2
E10.5 5 11 5
E14.5 10 21 0
Born mouse (3w) 12 14 0
   
E9.5 +/- E9.5 -/- Open neural tube
     
E10.5 +/- E10.5 -/-E10.5 +/+ Open neural tube
Wt allele
Floxed allele
exon2
loxP loxP
5’gRNA 3’gRNA
exon7
Knockout allele loxP loxP
exon7
7.5 kb
5’ to 3’ Exoribonuclease domain
Edc4 binding site
mXrn1 1723
1174 166926 - 237
Floxed exon
+ Cre
Figure 3.1| Xrn1 knockout mice were embryonic lethal.
(A) The domain organization of mouse Xrn1 protein and diagram of the wild-type Xrn1 
allele, the flox allele, and the knockout allele. Positions of exons, loxp sequences (white 
triangles), and 5’ and 3’ gRNAs (red line) are shown. (B) Number of embryos observed 
in indicated stages in each genotype. Pictures of Xrn1+/+, Xrn1+/-, and Xrn1-/- embryos at 
indicated embryonic day.
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mXrn1
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α-Tubulin
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E9.5 – E10.5 embryos   
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C-terminal detect
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XRN1
(C-terminal detect)
α-Tub lin
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B
Figure 3.2| Xrn1 knockout embryos express truncated protein.
(A) Immunoblotting for Xrn1 and α-Tubulin in Xrn1 WT, HE, and KO at E9.5 and E10.5 
embryos. (B) Diagram of mouse Xrn1 full length protein and truncated protein.
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Figure 3.3| Forebrain specific Xrn1 knockout mice were obese.
Growth curve of Xrn1flox/flox, Camk2a-Cre, and Xrn1-BKO male (A) and female (B) mice 
from 3 to 12 weeks after birth. Number of mice used for the experiment is indicated in 
each figure. Data represents mean ±SD. Two-Way ANOVA, *p<0.05; **p<0.01; 
***p<0.001; and ****p<0.0001. 
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3.2 Forebrain specific Xrn1 knockout mice were obese 
Whole-body homozygous deficiency of the Xrn1 gene was lethal in embryo (Figure 3.1). 
Therefore, in order to investigate physiological function of Xrn1 in adult brain, I generated 
forebrain specific Xrn1 knockout mice (Xrn1-BKO) by crossing Xrn1flox/flox mice and Camk2a-
cre mice. Surprisingly, Xrn1-BKO showed obesity under normal chow diet in both male and 
female mouse (Figure 3.3). A significant weight gain appeared at 6 weeks of age in both genders, 
but male mice at weaning period (3 to 4 weeks of age) were significantly smaller than control 
mice. Also, Xrn1-BKO mice had longer body length that of control littermates (Figure 3.4). 
Based on these results, I hypothesized that loss of Xrn1 in brain causes dysregulation in 
metabolism and energy homeostasis. 
 
3.3 Xrn1-BKO mice exhibited hyperphagia, adiposity, and liver steatosis 
Since I observed severe weight gain in Xrn1-BKO mice, next I examined daily food intake in 
both young period (6 – 7 weeks of age) and adult period (12 – 13 weeks of age). Mice were 
single-caged and daily food intake per cage under normal-chow diet was measured by 
calculating the difference between the initial and the remaining amount of food. There were 
significant differences between control mice and Xrn1-BKO mice in both male and female 
(Figure 3.5). 
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Figure 3.4| Appearance of Xrn1 knockout mice.
(A) Picture of 13-week-old male Xrn1flox/flox and Xrn1-BKO littermates. (B) Comparison 
of body length (right) of 12-week-old Xrn1flox/flox and Xrn1-BKO mice. Data represents 
mean ±SD. Unpaired t-test, *p<0.05; **p<0.01; ***p<0.001; and ****p<0.0001. 
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This result clearly showed that Xrn1-BKO mice are hyperphagic. Next, to check whether the 
weight gain is actually caused by the increase in fat mass, I dissected Xrn1-BKO mice and 
control mice to compare the weight of adipose tissues and liver. In Xrn1-BKO mice, I observed 
an increase in adipose tissues weight (inguinal white adipose tissue (iWAT), epididymal white 
adipose tissue (eWAT), and brown adipose tissue (BAT)) and liver weight (Figure 3.6). Also, 
I examined the weight of brain. Interestingly, brain was smaller than control littermates (Figure 
3.6), although the cause is unknown. To check the Xrn1 knockout efficiency in brain, I 
examined Xrn1 protein expression in various brain regions. I found that Xrn1 protein is 
decreased in cortex, hippocampus, midbrain, and hypothalamus in Xrn1-BKO (Figure 3.7A). I 
also examined Xrn1 protein expression in peripheral tissues. I found that Xrn1 protein is 
increased in liver and thymus, but not changed in iWAT, pancreas, and muscle (Figure 3.7B). 
In brain and peripheral tissue lysates, I couldn't observe the truncated Xrn1 protein expressed 
in whole-body Xrn1 knockout embryos. 
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Figure 3.5| Xrn1-BKO mice exhibited hyperphagia. 
Comparison of average daily food intake in young period and adult period of each 
genotype in both genders. Data represents mean ±SD. Two-Way ANOVA, post-hoc 
Tukey test, *p<0.05; **p<0.01; ***p<0.001; and ****p<0.0001. 
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Figure 3.6| Xrn1-BKO mice exhibited adiposity, and liver steatosis.
(A) Gross appearance of eWAT, iWAT, BAT, Liver, and brain in 12-week-old Xrn1flox/flox 
and Xrn1-BKO littermates. (B) Tissue weights of Xrn1 flox/flox and Xrn1-BKO mice at 12 
weeks of age. Data represents mean ±SD. Unpaired t-test, *p<0.05; **p<0.01; 
***p<0.001; and ****p<0.0001. 
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Figure 3.7| Expression of Xrn1 protein in mouse brain and peripheral 
tissues.
Immunoblotting for Xrn1, α-Tubulin, and Gapdh in Xrn1-BKO and control (Xrn1flox/+) 
female mice at 12 weeks of age. (A) Lysate from brain and (B) other tissues.
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3.4 Xrn1-BKO mice exhibited hyperglycemia, hyperleptinemia, and hyperinsulinemia 
To address the relationship between increased fat masses in Xrn1-BKO mice and adipocyte 
function, I examined glucose and lipid metabolism and found that the levels of circulating blood 
glucose, serum leptin, and serum insulin were significantly higher in Xrn1-BKO mice than 
control mice (Figure3.8). I also examined levels of circulating blood glucose in young period 
(5 – 6 weeks of age) and found that there was no significant difference, but I observed a 
tendency toward an increase in blood glucose level in 6 weeks of age of Xrn1-BKO mice. Thus, 
together with the body weight data, the development of obesity and diabetes like phenotypes 
starts around 6 weeks of age in Xrn1-BKO mice. In obesity and diabetes model mice, leptin 
resistance and insulin resistance are often observed (Balland and Cowley 2015, Huang et al. 
2018).  
3.5 Metabolic alteration in Xrn1-BKO mice 
I next measured whole-body metabolism by using calorimeter and found that loss of Xrn1 in 
brain resulted in a significant increase in CO2 production (Figure 3.9A). There were no 
differences in O2 consumption but increased energy expenditure (Figure 3.9B, D). Interestingly, 
Xrn1-BKO mice showed significant increase in respiratory exchange ratio (RER) (Figure 3.9C), 
which is calculated by VCO2/VO2. RER is the indicator of energy source. If carbohydrates are 
only used as the energy source, RER becomes 1.0. On the other hands, if fat is solely used as 
the energy source, RER will be 0.7. In control mice, RER is oscillating during a day, however, 
Xrn1-BKO mice showed constant RER and the value is about 1.0. These results indicate that 
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lack of Xrn1 in brain altered whole-body energy substrate utilization. I also measured activity 
of mice using home cage activity monitoring system and I didn’t observe significant difference 
although there was a decrease in activity during light period in Xrn1-BKO mice (Figure 3.10). 
The variance in control mice were huge in this experiment, thus further investigation of Xrn1-
BKO activity is required. 
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Figure 3.8| Xrn1-BKO mice exhibited hyperglycemia, hyperleptinemia, 
and hyperinsulinemia.  
(A) Levels of circulating random blood glucose in each age. (B-C) Levels of circulating 
serum leptin (B) and insulin (C) concentration measured by ELISA. Data represents 
mean ±SD. Unpaired t-test (two sample groups). Two-Way ANOVA, post-hoc Tukey test 
(three sample groups), *p<0.05; **p<0.01; ***p<0.001; and ****p<0.0001. 
 
  
**p<0.01. 
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Figure 3.9| Xrn1-BKO mice displayed increased VCO2, energy 
expenditure, and constant RER. 
(A) Oxygen consumption, (B) carbon dioxide production, (C) respiratory exchange 
ratio (RER), and (D) energy expenditure of 6 to 7-week-old mice were measured. RER 
is calculated by VCO2 divided by VO2. RER equals to 1.0 means carbohydrate is 
dominant energy source. RER equals to 0.7 means fat is dominant energy source. 
Data represents mean ±SEM. Unpaired t-test, *p<0.05; **p<0.01; ***p<0.001; and 
****p<0.0001. 
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3.6 Xrn1-BKO mice exhibited upregulation of appetite and energy homeostasis related 
genes in hypothalamus 
The above data suggest that Xrn1-BKO mice had a defect in appetite and energy homeostasis 
control. The hypothalamus controls energy homeostasis by receiving and integrating metabolite 
signals such as hormones and blood glucose levels from the peripheral tissues including liver, 
pancreas, and adipose tissue (St-Pierre and Tremblay 2012). A well-known neural circuit that 
controlling appetite and energy homeostasis in hypothalamus is the melanocortin system. In the 
arcuate nucleus of the hypothalamus (ARC), anorexigenic proopiomelanocortin (POMC) 
expressing neurons and orexigenic agouti-related protein (AgRP) expressing neurons exist. 
Both neurons are projecting to the paraventricular nucleus of the hypothalamic (PVH) and 
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Figure 3.10| Xrn1-BKO mice didn’t show statistical changes in activity.
(A) Home cage activity monitoring of 6 to 8-week-old male mice. Data represents mean 
±SEM. Unpaired t-test, *p<0.05; **p<0.01; ***p<0.001; and ****p<0.0001. 
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dorsomedial nucleus of the hypothalamus (DMH) where melanocortin receptor expressing 
neurons are present. POMC is a precursor of α-melanocyte stimulating hormone (α-MSH), and 
α-MSH is a ligand of melanocortin receptors, MC3R and MC4R (Pritchard, Turnbull, and 
White 2002). Upregulation of melanocortin receptor signaling in hypothalamus causes satiety. 
AgRP is an antagonist of the melanocortin receptor signaling pathway, thus overexpression of 
AgRP leads to hyperphagia and obesity (Graham et al. 1997, Ollmann et al. 1997). Activity of 
both POMC and AgRP neurons are regulated by hormones such as leptin and insulin, and also 
by nutrients such as glucose via JAK-STAT signaling pathways and PI3K-AKT signaling 
pathways (Belgardt, Okamura, and Brüning 2009, Wunderlich, Hövelmeyer, and Wunderlich 
2013, Huang et al. 2018) 
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Figure 3.11| Xrn1-BKO mice exhibited upregulation of appetite and 
energy homeostasis related genes in hypothalamus. 
Quantitative PCR analysis of the indicated mRNA levels in hypothalamus of 10 to 14-
week-old male mice. Data represents geometric mean ±SEM. Two-Way ANOVA, post-
hoc Tukey test, *p<0.05; **p<0.01; ***p<0.001; and ****p<0.0001.  
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Based on the above fact, I performed quantitative real-time PCR (qPCR) analysis in 
hypothalamus and found that the levels of mRNAs relevant to appetite and energy homeostasis 
were increased in hypothalamus of Xrn1-BKO mice. Those included mRNAs encoding AgRP 
and inhibitors of Jak-Stat and PI3K-Akt signaling pathway, Socs3, Ptp1b, and Tcptp (Figure 
3.11). Next, I performed immunoblotting to check protein expression in hypothalamus and 
found that Socs3 and Irs1 were upregulated in Xrn1-BKO mice (Figure 3.12). Moreover, I also 
observed increased AgRP protein expression and decreased Pomc expression in ARC in Xrn1-
BKO mice by immunohistochemistry (Figure 3.13).  
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Figure 3.12| Leptin and insulin signaling related protein expression in 
Xrn1-BKO mice hypothalamus.  
(A) Immunoblot of hypothalamus lysate from 12 to 14-week-old male mice. (B) Protein 
quantification of subunits normalized relative to α-tubulin levels. WT values were 
normalized to 1. Data represents mean ±SEM. Two-Way ANOVA, post-hoc Tukey test, 
*p<0.05; **p<0.01; ***p<0.001; and ****p<0.0001.  
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Figure 3.13| Xrn1-BKO mice displayed increased AgRP expression and 
decreased Pomc expression in hypothalamus. 
(A) Immunostaining for AgRP (red) and counterstained with DAPI (blue) in Xrn1-BKO 
and control (Xrn1flox/flox) mice at 12 weeks of age (B) Immunostaining for Pomc (red) and 
counterstained with DAPI (blue) in Xrn1-BKO and control (Xrn1 flox/flox) mice at 12 weeks 
of age. (C, D) Quantification of AgRP staining and Pomc staining. Data represents mean 
±SEM. Unpaired t-test, *p<0.05; **p<0.01; ***p<0.001; and ****p<0.0001. 
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3.6 Proteomics analysis in Xrn1-BKO hypothalamus 
To investigate the relationships between protein expression and observed abnormalities in 
Xrn1-BKO mice, I performed comprehensive proteomics analysis using Mass spectrometer. I 
could identify 3632 proteins by Mass spec. In hypothalamus of Xrn1-BKO mice, 44 proteins 
significantly increased more than 1.5-fold compared to those of control mice. Conversely, 76 
proteins in Xrn1-BKO hypothalamus significantly decreased more than 1.5-fold (Figure 3.14). 
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Figure 3.14| Volcano plot from the proteomics analysis in hypothalamus.  
Volcano plot showing log2 fold change (BKO/control) and adjusted p-values. Red dots 
represent proteins having significant adjusted p-values (adj. p-value < 0.05), yellow dots 
represent proteins having fold-change larger than 2 but not significant. Green dots 
represent proteins having fold-change larger than 2 and significant adjusted p-values. 
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Table 3.1| Differentially expressed proteins related to metabolism and hormone signaling.  
Gene name Description log2 Fold Change Adj. P-Value 
Vldlr Very low-density lipoprotein receptor 3.64 2.2E-10 
Aldob Fructose-bisphosphate aldolase B 2.18 2.5E-03 
Ephx2 Bifunctional epoxide hydrolase 2 2.13 2.2E-03 
Cyth3 Cytohesin-3 2.09 2.5E-03 
Mcat Malonyl-CoA-acyl carrier protein transacylase 2.08 4.1E-06 
Nsg1 Neuronal vesicle trafficking-associated protein 1 1.81 1.5E-02 
Mtor Serine/threonine-protein kinase mTOR 1.3 1.1E-02 
Apoe Apolipoprotein E 0.85 6.7E-03 
Fabp3 Fatty acid-binding protein, heart 0.71 3.7E-02 
Flot1 Flotillin-1 -0.79 2.7E-02 
Flot2 Flotillin-2 -0.8 2.5E-02 
Acot7 Cytosolic acyl coenzyme A thioester hydrolase -0.89 7.7E-03 
Acacb Acetyl-CoA carboxylase 2 -0.95 2.7E-03 
Vamp2 Vesicle-associated membrane protein 2 -0.96 4.0E-03 
Hras1 GTPase HRas -1.09 1.1E-02 
Atp6v1f V-type proton ATPase subunit F -1.34 1.0E-03 
Akt3 RAC-gamma serine/threonine-protein kinase -1.89 1.1E-04 
 
Table 3.2| Differentially expressed proteins related to brain. 
Gene name Description log2 Fold Change Adj. P-Value 
Cacnb3 Voltage-dependent L-type calcium channel subunit beta-3 3.23 3.3E-05 
Gabrg2 Gamma-aminobutyric acid receptor subunit gamma-2 1.87 1.5E-05 
Pvalb Parvalbumin alpha 0.91 1.7E-02 
Gls Glutaminase kidney isoform, mitochondrial -0.76 4.1E-02 
Sytl4 Synaptotagmin-like protein 4 -0.82 1.9E-02 
Cnrip1 CB1 cannabinoid receptor-interacting protein 1 -0.82 4.0E-02 
Gabrb1 Gamma-aminobutyric acid receptor subunit beta-1 -1.3 3.9E-03 
Cox7a2 Cytochrome c oxidase subunit 7A2, mitochondrial -1.35 3.7E-04 
Ngb Neuroglobin 1 -1.44 1.5E-03 
Th Tyrosine 3-monooxygenase -1.86 1.5E-02 
Astn2 Astrotactin-2 -3.82 3.5E-15 
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Table 3.3| Differentially expressed proteins related to mRNA metabolism. 
Gene name Description log2 Fold Change Adj. P-Value 
Lsm14b Protein LSM14 homolog B 3.48 3.5E-15 
Poldip3 Polymerase delta-interacting protein 3 2.58 1.1E-04 
Ddx6 Probable ATP-dependent RNA helicase DDX6 1.85 8.7E-13 
Ybx1 Nuclease-sensitive element-binding protein 1 1.79 7.8E-03 
Celf2 CUGBP Elav-like family member 2 0.83 1.9E-02 
Sf3b3 Splicing factor 3B subunit 3 -0.94 4.4E-02 
Rpl22 60S ribosomal protein L22 -1.01 1.8E-02 
Rnmt mRNA cap guanine-N7 methyltransferase -1.08 1.6E-02 
Hnrnph2 Heterogeneous nuclear ribonucleoprotein H2 -1.53 3.9E-06 
Csad Cysteine sulfinic acid decarboxylase -1.81 6.9E-05 
Dkc1 H/ACA ribonucleoprotein complex subunit DKC1 -2.2 2.4E-03 
 
To characterize protein expression differences in hypothalamus, I created the lists of 
the upregulated and downregulated proteins in different biological process (Table 3.1-3). 
Mammalian or mechanistic target of rapamycin (mTOR) senses and integrates various signals 
and regulates many cellular and physiological processes including energy homeostasis in 
hypothalamus by controlling through a PI3K/Akt-mediated pathway (Hu, Xu, and Liu 2016). 
Also, it is known that gamma-Aminobutyric acid (GABA) has a major role in feeding (Horvath 
et al. 1997) . AgRP neurons produce GABA and inhibit POMC neurons by GABAergic-
mediated inhibition (Cowley et al. 2001, Tong et al. 2008).  
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Figure 3.15| Validation of the result of the proteomics analysis by 
qPCR and immunoblotting. 
(A) qPCR analysis of the indicated mRNA levels in hypothalamus of 10 to 14-week-old 
male mice. (B) Immunoblotting of hypothalamus lysate from 11-week-old male mice. 
(C) Protein quantification of indicated proteins. Data represents geometric mean ±SEM. 
Unpaired t-test, *p<0.05; **p<0.01; ***p<0.001; and ****p<0.0001. 
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Therefore, I examined mRNA expression of mTor and GABA receptors by qPCR 
analysis (Figure 3.15A). The result showed that mTor mRNA was significantly increased in 
Xrn1-BKO hypothalamus. On the other hand, GABA receptor Gabrg2 was not changed and 
Gabrb1 was slightly increased although Gabrb1 was screened as downregulated protein in mass 
spec analysis (Figure 3.15A). To confirm protein upregulation of mTor, I performed 
immunoblotting by using the same lysate that I used in proteomics analysis. Unfortunately, I 
couldn’t validate the upregulation of mTor by immunoblotting (Figure 3.15B). However, 
upregulation of Ddx6, which is an RNA helicase, was validated. Thus, further investigation of 
the result of proteomics analysis is required. 
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Chapter 4 Discussion 
4.1 Functions of Xrn1 in embryo genesis 
The aim of my thesis study was to establish Xrn1 knockout mice for the first time and to analyze 
its phenotypes. In the first part of my thesis, I have shown that mice homozygously knockout 
for Xrn1, a gene encoding a major 5’ - 3’ exoribonuclease, are embryonic lethal and show open 
neural tube defects during embryogenesis (Figure 3.1). This result is consistent with the studies 
in different model organisms. RNAi mediated xrn1 knockdown in C. elegans embryos leads to 
failure of ventral enclosure (Newbury and Woollard 2004). Drosophila having mutation in 
PACMAN (XRN1) show developmental defects including a cleft thorax phenotype (Grima et al. 
2008). The epithelial sheet movement and enclosure are required to fulfill embryo development 
and wound healing. Ventral enclosure in C. elegans, dorsal/thorax closure in Drosophila, and 
neural tube closure in higher vertebrate have been shown to be a similar morphological process 
(Jacinto, Martinez-Arias, and Martin 2001, Jacinto, Woolner, and Martin 2002). Therefore, my 
data provide the evidence that the function of Xrn1 in epithelial fusion is also conserved in 
rodents, although the key target mRNAs behind the mechanisms are still unknown. The cleft 
thorax phenotype observed in PACMAN (XRN1) mutant flies is similar to that of the flies having 
mutation in c-Jun N-terminal kinase (JNK) signal pathway (Agnès, Magali, and Noselli 1999). 
Also, loss of function mutation in both JNK1/JNK2 causes neural tube defects in mice 
(Sabapathy et al. 1999). Thus, it is possible that Xrn1 influences epithelial sealing mechanism 
by regulating JNK signaling pathway. 
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4.2 Xrn1 controls energy homeostasis in hypothalamus 
The global epidemic of obesity and diabetes is drawing attention as a social problem. 
The development of these diseases is caused by numerous biological processes. Therefore, 
many obesity model mice have been established and analyzed to expand our understanding 
(Yazdi, Clee, and Meyre 2015). The first obesity model mice were discovered in 1950 (Ingalls, 
Dickie, and Snell 1950). The gene responsible for the mutation is called ob. The ob/ob mice 
show hyperphagia, hyperinsulinemia, and hyperglycemia (Coleman and Hummel 1973). More 
than 40 years later, the ob gene was cloned and identified as an adipocyte derived peptide 
hormone, leptin (Zhang et al. 1994, Kanasaki and Koya 2011). Another mutant mouse line that 
develops severe obesity was reported in 1967. This mutation was named db, and db/db mice 
also exhibit persistent hyperphagia and obesity, resulting in hyperglycemia, hyperinsulinemia, 
and hyperleptinemia (Coleman and Hummel 1967). The db gene was cloned and identified as 
a receptor of leptin (Chen et al. 1996). In recent decades, it becomes more evident that genetic 
defects in the leptin signaling pathway are associated with the development of obesity and 
diabetes (Yazdi, Clee, and Meyre 2015). In my thesis study, I provide evidence that forebrain 
specific knockout of the 5’-3’ exoribonuclease Xrn1 causes obesity. Also, these mice exhibit 
hyperphagia, resulting in hyperglycemia, hyperinsulinemia, and hyperleptinemia. I further 
showed that leptin signaling related gene expressions are altered in the hypothalamus of Xrn1-
BKO mice. 
 In obesity model mice, hyperleptinemia is often observed. In normal conditions, 
increased adiposity leads to more leptin production. An increase in circulating leptin levels is 
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detected by the hypothalamus and causes metabolic shifts to maintain energy homeostasis. 
However, obese individuals are less sensitive to leptin. Thus, they are resistant to leptin’s 
anorexigenic effect. This phenomenon is called “leptin resistance” (St-Pierre and Tremblay 
2012). Previous studies have shown that leptin resistance is caused by various mechanisms such 
as endoplasmic reticulum (ER) stress, inflammation, and attenuation of leptin signaling by 
SOCS3 and protein tyrosine phosphatases (Bjørbæk et al. 1998, Zhang et al. 2008, White et al. 
2009, Loh et al. 2011, St-Pierre and Tremblay 2012, Tanti et al. 2013). I showed that Xrn1-
BKO mice are obese and their serum leptin levels are high (Figure 3.3 and 3.8). Also, Socs3, 
Ptp1b, and Tcptp mRNA were upregulated in Xrn1-BKO hypothalamus (Figure 3.11-12). These 
results indicate that Xrn1-BKO mice developed leptin resistance. However, upregulation of 
leptin resistance genes might be the consequence of obesity, rather than the cause of it. For 
example, Socs3 overexpression in leptin receptor neurons does not lead to obesity but rather a 
lean phenotype (Reed et al. 2010). In addition, AgRP neuron specific Socs3 overexpression 
doesn’t cause obesity, but show the phenotype similar to that of observed in short-term 
consumption of a high-fat diet (Olofsson et al. 2013). Pomc neuron-specific Socs3 
overexpression causes obesity, but the weight gain is not severe and they are not hyperphagic 
(Reed et al. 2010). Therefore, the upregulation of leptin resistance-related genes is less likely 
to be the primary effect of loss of Xrn1 in the brain. 
 Xrn1-BKO mice are not only obese but also their body was longer than that of 
littermates (Figure 3.4). Interestingly, ob/ob and db/db mice don't show an increase in body 
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length, rather they are shorter than their littermates (Dubuc 1976, Graham et al. 1997). On the 
other hands, AgRP overexpression mutant mice, Pomc knockout mice, Mc4r knockout mice, 
and MC4R deficiency human patients have longer body length (Huszar et al. 1997, Ollmann et 
al. 1997, Graham et al. 1997, Yaswen et al. 1999, Farooqi et al. 2003). It indicates that the 
phenotypes observed in Xrn1-BKO mice are related to the defects in the melanocortin receptor 
signaling pathway. Xrn1-BKO mice exhibit constant RER, indicating a metabolic shift of 
energy source (Figure 3.9C). A recent study has shown that activation of AgRP neurons alters 
whole-body substrate utilization (Cavalcanti-de-Albuquerque et al. 2019). In this paper, the 
authors showed that AgRP neuron regulates lipogenesis and glycolysis in white adipose tissue 
via sympathetic signaling. In consequence, activation of AgRP neurons leads to a shift in RER. 
AgRP mRNA and protein expressions are elevated in the hypothalamus of Xrn1-BKO mice 
(Figure 3.11 and 3.13). Based on the above fact, AgRP might be a primary target of Xrn1 in the 
hypothalamus, as observed phenotypes are consistent with known AgRP overexpression mice. 
Although further investigations in peripheral tissues are required to conclude that metabolic 
alteration of Xrn1-BKO is due to dysregulation of lipogenesis and glycolysis. Previous studies 
have shown that Xrn1 regulates its target gene expression by controlling mRNA stability, 
transcription, and translation (Braun and Young 2014, Luchelli, Thomas, and Boccaccio 2015). 
Therefore, further comprehensive analyses are required to fully clarify the mechanisms of the 
upregulation of AgRP in Xrn1-BKO. It is also worth mentioning that we must keep in mind that 
this mouse model is forebrain specific conditional knockout. Consideration should be given to 
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the possibility that loss of Xrn1 affects other brain regions such as cortex and hippocampus 
since I observed a reduction of Xrn1 protein in these regions (Figure 3.7).  
 Proteomics analysis has shown that more than 100 proteins are either upregulated or 
down regulated in Xrn1-BKO hypothalamus (Figure 3.14). The main purpose of this approach 
was to screen for novel potential Xrn1 target genes and proteins related to the observed 
phenotypes although I could only validate the upregulation of Ddx6 protein so far (Figure 
3.15B). DEAD box RNA helicase Ddx6 is a homologue of yeast Dhh1 and the major activator 
of the decapping enzyme Dcp1. Since decapping is coupled with subsequent 5’ to 3’ decay, 
Ddx6 is an indirect activator of Xrn1 (Fischer and Weis 2002). Ddx6 is one of the core 
components of P-bodies (Sheth and Parker 2003, Cougot, Babajko, and Séraphin 2004, Parker 
and Sheth 2007). It is worth mentioning that overexpression of Ddx6 leads to an increase in p-
bodies number and suppress translation in yeast (Coller et al. 2001). In Drosophila testis and 
eggs, Xrn1 is colocalized with Ddx6 in p-bodies (Zabolotskaya et al. 2008, Lin et al. 2008). 
Hypomorphic mutations in Xrn1 causes male and female infertility, and dramatically increase 
the number of p-bodies in Drosophila testis and eggs (Zabolotskaya et al. 2008, Lin et al. 2008). 
Also, overexpression of Ddx6 in neural stem cells (NSCs) leads to an increase in neuronal 
differentiation via activation of microRNA Let-7A (Nicklas et al. 2015). Therefore, Ddx6 is 
not directly related to obesity, but it is possible that overexpression of Ddx6 in Xrn1-BKO 
hypothalamus affects p-body formation or microRNA mediated gene silencing and causes 
inactivation of specific transcripts related to energy homeostasis in Xrn1-BKO hypothalamus.  
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In conclusion, I found that forebrain specific Xrn1 knockout causes defects in energy 
homeostasis and leads to obesity and hyperphagia. In principle, Xrn1 degrades bulk mRNAs, 
however, Xrn1-BKO mice exhibited very specific phenotype. Moreover, I found that 
dysregulated expression of appetite and energy homeostasis related genes in the hypothalamus 
of the knockout mice. This result suggests that either 5’-3’ decay in the brain has the particular 
target mRNAs or, majority of 5’-3’ decay targets are degraded by different decay pathways 
such as 3’-5’ decay in Xrn1-BKO mice. Therefore, elucidation of the molecular mechanisms of 
obesity and energy homeostasis regulation by Xrn1 would raise the possibility of developing 
therapeutic strategies to treat metabolic defects such as obesity and diabetes.  
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